Breeden Richard C 4
4 · STERIS plc · Filed May 16, 2023
Insider Transaction Report
Form 4
STERIS plcSTE
Breeden Richard C
Director
Transactions
- Sale
Ordinary Shares
2023-05-15$211.00/sh−2,737$577,507→ 40,100 total
Holdings
- 27,242(indirect: See Footnote Below)
Ordinary Shares
Footnotes (2)
- [F1]Price reflects a weighted average sale price for multiple transactions ranging from $211.00 to $211.02 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Mr. Breeden disclaims beneficial ownership over 1,359 of these shares held by Breeden Partnership LLP.